Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Making the News

 

Norway moves to increase patient choice

The Norwegian government is trying to introduce more free choice for patients, particularly when it comes to elderly care, with a new procurement framework. The move comes after a few years of Norwegian municipalities refusing to work with the for-profit sector.

Vithas puts weight behind new diagnostics division

Spain's second-largest hospital group Vithas has brought together its diagnostic arms into a new division called Vithas Diagnostics. It's headed by a new employee, who comes straight from Synlab.

Russia debates ban on spending public funds on capex

Russia has put forward draft proposals that forbid private providers from spending compulsory insurance funds on capital expenditure, the acquisition of property and the repayment of loans. Operators say it will likely halt all investment in the sector.

Max Healthcare raises $165m

India's second-largest for-profit hospital chain Max Healthcare has raised 1,200 crore ($160m) in a Qualified Institutions Placement (QIP), almost the exact same amount as Apollo Hospitals did in January.

Lifebrain for sale as EBITDA for lab groups near doubles

Italian lab group Lifebrain is the latest to take advantage of swollen revenues and profits in the lab sector with owner Investindustrial appointing Goldman Sachs and JP Morgan to explore a sale. Meanwhile, COVID-19 testing across Europe led to a near doubling of EBITDA for the largest players in the third quarter of 2020.

Which UK private hospitals earned the most from £2bn NHS block-booking?

NHS England will have spent around £2bn on buying capacity and services from the private hospital sector for COVID-19 related services in the last 12 months, according to recently-released public documents. We break out the figures to reveal which operators earned the most and how the picture changed in Q4. 

EMEA for-profit hospital sector shrinks 3-5% in 2020

Revenues in the EMEA for-profit hospital market fell by 3-5% in 2020 due to COVID-19 but could bounce back strongly in 2021, figures from HBI Intelligence show. NMC Health CEO Michael Davis tells HBI he anticipates a ‘return to normalcy’ to continue through the year. 

Vaccines causing minimal headwinds in COVID-19 testing volumes

HBI analysis of COVID-19 testing volumes and pricing reveals how vaccine programmes and the rise of antigen tests might impact future growth for the lab groups. PCR volumes and have dropped 16% in the UK since it started vaccinating its population and one lab group is expecting a 35% to 50% drop in COVID revenue this year.

Number of French assisted living sites “could double by 2030”

The number of assisted living sites in France is expected to more than double between now and 2030, according to Les Essentielles, an assisted living-focused subsidiary of Korian. HBI speaks to their executive director, Arnaud Choulet, and to Frédéric Walther, Managing Director of Domitys, to find out more. 

Find Us